Avadel Pharmaceuticals PLC (AVDL)
16.53
+0.71
(+4.49%)
USD |
NASDAQ |
May 10, 16:00
16.53
0.00 (0.00%)
After-Hours: 18:26
Avadel Pharmaceuticals Revenue (Quarterly): 19.45M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 19.45M |
| September 30, 2023 | 7.014M |
| June 30, 2023 | 1.496M |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | 10.09M |
| March 31, 2020 | 12.24M |
| December 31, 2019 | 11.00M |
| September 30, 2019 | 14.23M |
| June 30, 2019 | 17.55M |
| March 31, 2019 | 16.44M |
| December 31, 2018 | 20.92M |
| September 30, 2018 | 19.83M |
| June 30, 2018 | 29.23M |
| March 31, 2018 | 33.29M |
| December 31, 2017 | 34.75M |
| Date | Value |
|---|---|
| September 30, 2017 | 39.68M |
| June 30, 2017 | 46.31M |
| March 31, 2017 | 52.51M |
| December 31, 2016 | 43.08M |
| September 30, 2016 | 32.09M |
| June 30, 2016 | 38.86M |
| March 31, 2016 | 36.22M |
| December 31, 2015 | 44.57M |
| September 30, 2015 | 47.31M |
| June 30, 2015 | 48.60M |
| March 31, 2015 | 32.73M |
| December 31, 2014 | -9.31M |
| September 30, 2014 | 7.028M |
| June 30, 2014 | 4.318M |
| March 31, 2014 | 4.578M |
| December 31, 2013 | -12.08M |
| September 30, 2013 | 5.583M |
| June 30, 2013 | 5.541M |
| March 31, 2013 | 5.14M |
| December 31, 2012 | -11.26M |
| September 30, 2012 | 5.398M |
| June 30, 2012 | 6.033M |
| March 31, 2012 | 7.36M |
| December 31, 2011 | 8.649M |
| September 30, 2011 | 10.43M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.496M
Minimum
Jun 2023
19.45M
Maximum
Dec 2023
11.63M
Average
11.62M
Median
Revenue (Quarterly) Benchmarks
| Trinity Biotech PLC | 13.43M |
| Medtronic PLC | 8.089B |
| Akari Therapeutics PLC | -- |
| Biophytis SA | -- |
| TC BioPharm (Holdings) PLC | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.79M |
| Total Expenses (Quarterly) | 44.35M |
| EPS Diluted (Quarterly) | -0.29 |
| Enterprise Value | 1.328B |
| Gross Profit Margin (Quarterly) | 96.44% |
| Profit Margin (Quarterly) | -148.0% |
| Earnings Yield | -12.16% |
| Normalized Earnings Yield | -11.34 |